UTHSC In the Media


UTHSC official shares unique history with retired general Lloyd Austin

In the Media Icon

An official at the University of Tennessee Health Science Center has a unique history with Retired Army General Lloyd Austin. Love Collins III is the vice-chancellor of Development and Alumni Affairs for the University of Tennessee Health Science Center. He was track teammates with Austin at West Point in the mid-70s. They’ve known each other… Read More


 Lyft: In 2020, rideshare drivers and bikeshare access helped millions of people stay connected to essentials.

In the Media Icon

We developed a recommended rideshare-specific cleaning process in partnership with P&G Professional and the University of Tennessee Health Science Center, a leader in combating viral pathogens. Local teams have performed thousands of cleaning services at our Driver Centers.


West Clinic settles in lawsuit alleging kickback scheme with Methodist Le Bonheur

The Commercial Appeal

West Clinic has agreed to a settlement in a lawsuit alleging physicians for the Memphis institution took part in a yearslong kickback arrangement, according to a court filing Tuesday. The lawsuit was filed by two high-ranking Memphis healthcare executives: Methodist University Hospital President Jeff Liebman and David Stern, former executive dean and vice chancellor at… Read More


Knoxville Biz Ticker: UTHSC College of Medicine launches 3-year accelerated curriculum program

In the Media Icon

The College of Medicine at the University of Tennessee Health Science Center is pleased to launch an accelerated curriculum program to allow students committed to practicing in primary care fields to complete their medical education and training in three years, instead of the customary four years.


 UTHSC hosting CDC director in virtual conversation

In the Media Icon

The University of Tennessee Health Science Center will host a conversation with Dr. Robert R. Redfield, director of the Centers for Disease Control and Prevention, from 11 a.m. to noon, Monday, Dec. 14.


Veru Expands Oncology Drug Pipeline; Exclusively Licenses Phase 3 Clinical Stage Targeted Therapy for Endocrine Resistant Metastatic Breast Cancer

In the Media Icon

Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancer, today announced that it has exclusively licensed worldwide rights to enobosarm, a late-stage oral novel androgen receptor (AR) targeting agent for the treatment of endocrine resistant ER+ HER2- metastatic breast cancer.… Read More


Cellworks Personalized Biosimulation Clinical Trial Predicted ATO and ATRA Therapy Response in APL Patients with 93% Accuracy

In the Media Icon

Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology, today announced results from the myCare-021-01 clinical trial, which found that the Cellworks Omics Biology Model (CBM) predicted response to Arsenic Trioxide (ATO) and All-trans-retinoic Acid (ATRA) in Acute Promyelocytic Leukemia (APL) patients harboring PML-RARA fusions with… Read More


UTHSC rolls out 3-year program for primary care physicians

In the Media Icon

By 2030, Tennessee, which has about 4,000 general practice physicians, is expected to need 1,100 more, a 25% increase, as the population both grows and ages. To help, the University of Tennessee Health Science Center is adding a chance to earn a medical degree in three years instead of four — saving in-state students about… Read More